Silo Pharma, Inc.
SILO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $6,439 | $3,956 | $5,247 | $3,991 |
| - Cash | $3,918 | $4,334 | $3,137 | $3,906 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $2,521 | -$377 | $2,110 | $85 |
| Revenue | $18 | $18 | $18 | $18 |
| % Growth | 0% | -0% | 0% | – |
| Gross Profit | -$233 | $17 | $17 | -$382 |
| % Margin | -1,291.2% | 91.9% | 91.9% | -2,118.3% |
| EBITDA | -$1,107 | -$1,200 | -$1,026 | -$1,791 |
| % Margin | -6,139.3% | -6,658.4% | -5,693.3% | -9,936.5% |
| Net Income | -$1,110 | -$1,204 | -$1,031 | -$1,731 |
| % Margin | -6,160.5% | -6,681.2% | -5,721.9% | -9,600.7% |
| EPS Diluted | -0.12 | -0.19 | -0.23 | -0.39 |
| % Growth | 36.8% | 17.4% | 41% | – |
| Operating Cash Flow | -$955 | -$1,285 | -$1,640 | -$917 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$955 | -$1,285 | -$1,640 | -$917 |